PL3164492T3 - Układy ekspresji polipeptydu - Google Patents

Układy ekspresji polipeptydu

Info

Publication number
PL3164492T3
PL3164492T3 PL15739141T PL15739141T PL3164492T3 PL 3164492 T3 PL3164492 T3 PL 3164492T3 PL 15739141 T PL15739141 T PL 15739141T PL 15739141 T PL15739141 T PL 15739141T PL 3164492 T3 PL3164492 T3 PL 3164492T3
Authority
PL
Poland
Prior art keywords
expression systems
polypeptide expression
polypeptide
systems
expression
Prior art date
Application number
PL15739141T
Other languages
English (en)
Inventor
Isidro Hotzel
Yonglei Shang
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3164492T3 publication Critical patent/PL3164492T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL15739141T 2014-07-03 2015-07-02 Układy ekspresji polipeptydu PL3164492T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462020838P 2014-07-03 2014-07-03
US201462080698P 2014-11-17 2014-11-17
EP15739141.8A EP3164492B1 (en) 2014-07-03 2015-07-02 Polypeptide expression systems
PCT/US2015/039086 WO2016004370A1 (en) 2014-07-03 2015-07-02 Polypeptide expression systems

Publications (1)

Publication Number Publication Date
PL3164492T3 true PL3164492T3 (pl) 2020-04-30

Family

ID=53674343

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15739141T PL3164492T3 (pl) 2014-07-03 2015-07-02 Układy ekspresji polipeptydu

Country Status (9)

Country Link
US (2) US10308944B2 (pl)
EP (2) EP3164492B1 (pl)
JP (5) JP6694400B2 (pl)
CN (2) CN113789339A (pl)
ES (1) ES2763526T3 (pl)
HR (1) HRP20192243T1 (pl)
PL (1) PL3164492T3 (pl)
SI (1) SI3164492T1 (pl)
WO (1) WO2016004370A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2870247T3 (pl) * 2012-07-05 2019-10-31 Hoffmann La Roche Układ ekspresji i wydzielania
HRP20192243T1 (hr) * 2014-07-03 2020-03-06 F. Hoffmann - La Roche Ag Polipeptidni ekspresijski sustavi
CA3135490A1 (en) 2019-03-29 2020-10-08 Salk Institute For Biological Studies High-efficiency reconstitution of rna molecules
JP2022538598A (ja) * 2019-06-25 2022-09-05 ミガル ガリラヤ リサーチ インスティテュート リミテッド プレｍＲＮＡのトランススプライシングに基づく合成転写用論理「ＡＮＤ」ゲートを作製するためのシステムおよびその使用
CA3157799A1 (en) * 2019-11-11 2021-05-20 Salk Institute For Biological Studies Compositions and methods for high-efficiency recombination of rna molecules
JP7643841B2 (ja) 2020-07-01 2025-03-11 カヤバ株式会社 リリーフ弁

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
US6150141A (en) * 1993-09-10 2000-11-21 Trustees Of Boston University Intron-mediated recombinant techniques and reagents
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
US20030027250A1 (en) * 1995-12-15 2003-02-06 Mitchell Lloyd G. Methods and compositions for use in spliceosome mediated RNA trans-splicing
EP0883344B2 (en) 1995-12-15 2010-06-09 VIRxSYS Corporation Therapeutic molecules generated by trans-splicing
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
WO1999029888A1 (en) 1997-12-05 1999-06-17 The Scripps Research Institute Humanization of murine antibody
CA2330191A1 (en) 1998-06-03 1999-12-09 Scios, Inc. Protease inhibitor peptides
PT2857516T (pt) 2000-04-11 2017-08-28 Genentech Inc Anticorpos multivalentes e utilizações dos mesmos
IL136459A0 (en) * 2000-05-30 2001-06-14 Galim Galil Immunology Ltd Antibody library
CA2434118A1 (en) * 2001-01-08 2002-07-11 Intronn, Inc. Spliceosome mediated rna trans-splicing
EP1427744B1 (en) * 2001-08-27 2007-12-26 Genentech, Inc. A system for antibody expression and assembly
CN1886512A (zh) * 2002-04-23 2006-12-27 斯克里普斯研究所 多肽在叶绿体中的表达以及用于表达多肽的组合物和方法
KR100465201B1 (ko) * 2002-07-16 2005-01-13 현대모비스 주식회사 안티로크 브레이크 시스템의 액압 제어용 전자식 밸브
AU2004204462B2 (en) * 2003-01-09 2012-03-08 Macrogenics, Inc. Dual expression vector system for antibody expression in bacterial and mammalian cells
CN1961003B (zh) 2004-03-31 2013-03-27 健泰科生物技术公司 人源化抗TGF-β抗体
US20060026422A1 (en) * 2004-07-29 2006-02-02 International Business Machines Corporation Method, apparatus, and product for providing a backup hardware trusted platform module in a hypervisor environment
JP5053850B2 (ja) * 2004-10-08 2012-10-24 バークシス コーポレーション 抗体遺伝子導入および抗体ポリペプチド産生のためのｒｎａトランススプライシングの使用
WO2007045465A1 (en) * 2005-10-21 2007-04-26 F. Hoffmann-La Roche Ag Method for the recombinant expression of a polypeptide
WO2007147901A1 (en) 2006-06-22 2007-12-27 Novo Nordisk A/S Production of bispecific antibodies
EP2471816A1 (en) 2006-08-30 2012-07-04 Genentech, Inc. Multispecific antibodies
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
JP2012503982A (ja) * 2008-09-26 2012-02-16 ワイス・エルエルシー 適合性ディスプレイベクター系
CN102712696A (zh) 2009-09-16 2012-10-03 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
HRP20181315T1 (hr) * 2010-11-22 2018-10-19 Amicus Therapeutics, Inc. Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina
PL2870247T3 (pl) * 2012-07-05 2019-10-31 Hoffmann La Roche Układ ekspresji i wydzielania
HRP20192243T1 (hr) * 2014-07-03 2020-03-06 F. Hoffmann - La Roche Ag Polipeptidni ekspresijski sustavi

Also Published As

Publication number Publication date
JP6694400B2 (ja) 2020-05-13
WO2016004370A1 (en) 2016-01-07
US20160002642A1 (en) 2016-01-07
JP2025118659A (ja) 2025-08-13
EP3164492A1 (en) 2017-05-10
JP2023081910A (ja) 2023-06-13
CN113789339A (zh) 2021-12-14
EP3680336A1 (en) 2020-07-15
ES2763526T3 (es) 2020-05-29
CN106574270B (zh) 2021-07-13
CN106574270A (zh) 2017-04-19
JP2020114219A (ja) 2020-07-30
JP7863949B2 (ja) 2026-05-22
US11851661B2 (en) 2023-12-26
US10308944B2 (en) 2019-06-04
JP2017520255A (ja) 2017-07-27
EP3164492B1 (en) 2019-10-23
JP2025097990A (ja) 2025-07-01
US20190256859A1 (en) 2019-08-22
HRP20192243T1 (hr) 2020-03-06
SI3164492T1 (sl) 2020-02-28

Similar Documents

Publication Publication Date Title
IL279836B (en) Aircraft system
IL251719B (en) Cyber security system
GB2533027B (en) Control system
GB201417453D0 (en) Location system
GB201421498D0 (en) Ventalation System
GB201410330D0 (en) Control system
GB201403908D0 (en) Communicatioon system
GB201506508D0 (en) Path control system
GB201418562D0 (en) Peptides
GB2525383B (en) Feature control system
SI3164492T1 (sl) Sistem polipeptidne ekspresije
GB2529291B (en) Actuator system
GB201401877D0 (en) Peptides
GB201411097D0 (en) 329 - octo-lateral system
SG10201500603SA (en) Monitoring-And-Control System
GB2528104B (en) Photographic-flash response system
GB201410686D0 (en) Peptides
GB201520986D0 (en) Control system
GB201415235D0 (en) Trans-locating peptide
GB201420645D0 (en) Peptides
GB201404910D0 (en) Trans-locating peptide
GB201417116D0 (en) Telescopic-lateral system
GB201417063D0 (en) System
GB201413642D0 (en) System
GB201411684D0 (en) Detecttion system